Acetyl-L-carnitine (nerve).
Crosses blood-brain barrier. Supports nerve regeneration. Supports nerve cell energy production and may help regenerate damaged nerve fibers. Same compound as regular ALCAR with nerve-focused positioning.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- NeuropathyNerve regenerationCognitive support
What Acetyl-L-Carnitine (Nerve) is, and what it does.
- Does it work
- If that is your concern, worth trying. Otherwise regular ALCAR works fine.
- How much to take
- 1000-3000mg daily in divided doses. Higher doses used in neuropathy studies.
- Time to feel it
- Nerve related outcomes are measured over three to twelve months of daily use. Any lift in mental clarity tends to appear in the first two to four weeks.
- The first dose
- No immediate nerve effects. This takes weeks to months.
- With regular use
- May reduce neuropathy symptoms over 6-12 months. Also provides standard ALCAR cognitive benefits.
- How well tolerated
- Same as regular ALCAR. Generally well-tolerated. May cause fishy odor at high doses.
- How it feels
- Gradual. Nerve benefits are slow to develop. Cognitive effects similar to standard ALCAR.
- The overlooked benefit
- Your body builds carnitine from lysine and methionine using vitamin C, iron and B6, so carnitine status leans on those cofactors as much as on intake.
500 to 1,500mg a day is where Acetyl-L-Carnitine (Nerve) works.
Source: Sima et al. J Clin Endocrinol Metab 2005; Examine.com ALCAR page
Questions people ask about Acetyl-L-Carnitine (Nerve).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
4 more questions
- Should I take it on an empty stomach?
- Most amino acids absorb better on an empty stomach since they don't compete with food proteins for absorption. 30 minutes before meals is ideal.
- Can I get enough from protein?
- If you eat enough protein (0.8-1g per pound bodyweight), you probably get enough aminos. Supplementing specific ones only makes sense for targeted goals.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula, 35 pairings
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
These are the same acetylated carnitine ester under different labels, so the amounts add rather than complement. Read the combined total when both appear on one panel.
The acetyl ester hydrolyses to free carnitine plus an acetyl group, so it contributes to the same total body pool as plain L-carnitine. The ester adds a distribution preference toward nervous tissue rather than a separate nutrient.
Acetylcholine is assembled from an acetyl group and choline, and acetyl-L-carnitine is a mobile donor of the acetyl half while alpha-GPC delivers the choline half. Supplying both covers the whole substrate requirement.
Choline acetyltransferase joins choline to an acetyl group carried by acetyl-CoA, and the acetyl ester of carnitine helps shuttle acetyl units to where that happens. Neither half builds the neurotransmitter alone.
Phosphatidylcholine supplies choline in a membrane-phospholipid form while the acetyl ester supplies the acetyl group for the same neurotransmitter step. It also feeds the membrane phospholipid pool nerve tissue draws on.
Lipoic acid is the cofactor for the dehydrogenase complexes that process the substrate carnitine transport delivers, and it regenerates other antioxidants in the same compartment.
Carnitine moves fatty acyl groups into the mitochondrion and CoQ10 moves the resulting electrons through the respiratory chain. Nerve tissue with high energy demand depends on both steps.
B12 is the cofactor for methylmalonyl-CoA mutase and for the methylation that maintains myelin, a requirement separate from the acetyl group transport carnitine supports.
Methylfolate keeps the methyl cycle running that supplies S-adenosylmethionine for phospholipid and myelin methylation. It covers a methylation requirement that carnitine, an energy-transport molecule, does not touch.
Acetyl-L-carnitine and a choline donor supply the raw material for acetylcholine, while huperzine A slows the esterase that breaks it back down. One side builds and the other side conserves.
Ascorbate is the cofactor for both hydroxylation steps that make carnitine from trimethyllysine. Vitamin C status shapes how much carnitine the body produces alongside what is supplied.
PQQ is associated with signalling toward mitochondrial biogenesis while carnitine governs what substrate those mitochondria receive. More mitochondria are only useful if fatty acids can reach them.
The body builds carnitine from lysine residues already incorporated into protein, with trimethyllysine as the first intermediate. Acetyl-L-carnitine is that same carnitine molecule carrying an acetyl group. Lysine supply therefore sits upstream of what the body makes itself, which is a different pool from what a supplement delivers directly.
Methionine, as S-adenosylmethionine, donates the three methyl groups that convert a lysine residue into trimethyllysine. Without that methyl supply the endogenous carnitine pathway stalls at its first step. This is a cofactor relationship in synthesis, not an effect on absorption of supplemental acetyl-L-carnitine.
Two of the four steps in carnitine biosynthesis are run by iron-dependent, ascorbate-requiring dioxygenases. Iron status is one of the inputs that determines how much carnitine a person makes from dietary precursors. It has no bearing on the acetyl group itself.
The aldolase step that releases 4-trimethylaminobutyraldehyde in carnitine synthesis uses pyridoxal 5-phosphate. B6 therefore sits inside the endogenous pathway alongside iron and ascorbate. A settled cofactor relationship rather than a tested combination.
Once the carnitine shuttle has moved a fatty acyl group into the mitochondrion, the first oxidation is performed by FAD-dependent acyl-CoA dehydrogenases. Riboflavin is the source of that FAD. Carnitine delivers the substrate. Riboflavin-dependent enzymes are what act on it next.
Pantothenate is the backbone of coenzyme A, and carnitine acetyltransferase works by swapping acetyl groups between CoA and carnitine in both directions. Acetyl-L-carnitine only functions as an acetyl reservoir because a CoA pool exists to trade with. Textbook biochemistry, no trial needed.
NAD supplied from niacin is the electron acceptor for the beta-oxidation spiral that follows carnitine-mediated fatty acid entry, and NADPH is needed for the reductase step in carnitine synthesis. The relationship is upstream and downstream cofactor supply. It says nothing about how well either is absorbed.
Thiamine pyrophosphate runs the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase steps that feed the same mitochondrial acetyl-CoA and TCA pool acetyl-L-carnitine buffers. The two act on opposite sides of the same node. Shared pathway, described from established biochemistry rather than a combination study.
Biotin-dependent carboxylases, including acetyl-CoA carboxylase and propionyl-CoA carboxylase, sit in the same fatty acid handling network as the carnitine shuttle. Where carnitine moves acyl groups across the membrane, these enzymes decide their fate. A cofactor adjacency, not a measured interaction.
Every ATP-dependent step in fatty acid activation, including the acyl-CoA synthetases that create the substrate carnitine carries, requires magnesium as the ATP counter-ion. Magnesium is a general requirement of the pathway rather than a partner specific to acetyl-L-carnitine.
Betaine remethylates homocysteine back to methionine, restocking the methyl pool that carnitine biosynthesis draws on. That makes it an indirect input to endogenous carnitine rather than a partner in the acetyl transfer step. Established one-carbon chemistry.
Resveratrol was one of four components given together with acetyl-L-carnitine, alpha-lipoic acid and cholecalciferol alongside a rehabilitation programme in a small clinical study. Because all four moved together, the design cannot attribute any part of the result to acetyl-L-carnitine alone. What it supports is that the combination has been used together and reported on.
Cholecalciferol appeared in the same four-nutrient rehabilitation regimen as acetyl-L-carnitine. The pairing is documented as a co-administration, not as an isolated interaction. Confidence stays at the level the design allows.
Long-chain omega-3 fatty acids are themselves carnitine-dependent substrates for mitochondrial entry, and they are incorporated into the membranes where that transport happens. The pairing is mechanistically coherent and commonly formulated. No trial of the two together grounds a specific effect size here.
Creatine buffers cytosolic ATP through the phosphocreatine system while carnitine governs how much fatty acid reaches the mitochondrion to regenerate that ATP. The two sit at different points of the same energy supply chain. Described from bioenergetics, not from a combination trial.
Ribose is a substrate for adenine nucleotide salvage, and acetyl-L-carnitine feeds the oxidative machinery that phosphorylates those nucleotides. The pairing is plausible on pathway grounds only. Nothing in the reviewed literature measures the two together.
Taurine is concentrated in mitochondria-rich tissue and supports mitochondrial protein translation, the same compartment where carnitine delivers its cargo. Both are also conditionally synthesised amino acid derivatives that fall when dietary intake is low. Mechanistic adjacency, described as such.
Beta-oxidation raises electron flux through the respiratory chain, and glutathione is the main thiol buffer handling the resulting peroxides in that compartment. Supporting substrate delivery without the matching thiol capacity is an incomplete picture. This is redox biochemistry, not an outcome claim.
N-acetylcysteine supplies the cysteine that rate-limits glutathione synthesis, which is the thiol pool serving mitochondria under high oxidative load. The link to acetyl-L-carnitine is through that shared compartment. Confidence reflects mechanism, not a measured combination.
Alpha-tocopherol terminates lipid radical chains inside the membranes across which carnitine shuttles acyl groups. The pairing is about protecting the lipid environment of the transport step. No combination measurement is cited for it.
Acetylcholine synthesis needs both a choline supply and an acetyl group from acetyl-CoA, and acetyl-L-carnitine contributes to the acetyl side of that ledger. CDP-choline covers the choline side. The two inputs are complementary by chemistry. The downstream effect on any function is not established from that alone.
Phosphatidylserine is a structural phospholipid of neuronal and mitochondrial membranes, the setting in which carnitine transport occurs. Formulators pair the two for that reason. The grounding is compositional rather than clinical.
Arginine appears as the counter-ion in acetyl-L-carnitine arginate, a salt used to change powder handling and taste. The arginine in that salt also contributes its own free amino acid load once dissociated. This is a formulation relationship, and the salt form should not be read as a different level of activity.
Nothing specific on file for Acetyl-L-Carnitine (Nerve). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Acetyl-L-Carnitine (Nerve) actually does.
Acetyl-L-carnitine is L-carnitine with an acetyl group attached. Carnitine is the shuttle mitochondria use to carry long fat chains inside so they can be burned for energy.
3 more mechanisms
It works as a mobile carrier for acetyl groups inside the cell, moving them between pools in both directions, rather than being a fuel in itself.
Cells absorb carnitine through a transporter that fills up, so blood levels flatten out as you take more instead of climbing in step with the dose.
Your body also makes its own carnitine from a protein-derived starting material, through a chain of steps that need iron, vitamin C, an active B vitamin form and methyl groups along the way.
Where Acetyl-L-Carnitine (Nerve) comes from.
It starts as L-carnitine, made either in a chemical plant or by fermentation, and then an acetyl group is attached in a second chemical step. The powder is crystallised, tested for the right mirror-image form, and packed dry because it soaks up moisture from the air.
What this route gives you
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
5 steps on record
Pharmaceutical L-carnitine is produced either by chemical synthesis with a resolution or asymmetric step to obtain the L enantiomer, or by microbial conversion of a crotonobetaine or gamma-butyrobetaine feed. Both routes are in commercial use and the certificate of analysis, not the marketing copy, is where the route is stated.
The hydroxyl group of L-carnitine is acetylated with an acetyl donor such as acetic anhydride or acetyl chloride under acid conditions, giving the acetyl ester. The reaction is where the D isomer must already have been excluded, since acetylation does not correct stereochemistry.
Crude product is taken up in solvent and crystallised, most often as the hydrochloride, then washed to strip residual acetylating agent and solvent. Free base material is isolated instead when the label declares the base, and it is handled under low humidity from this point on.
Assay by titration or chromatography sets the carnitine content, a chiral method confirms the L form, and residual solvent and heavy metal limits are checked. Enantiomeric purity is the specification that matters most here because the D form is not the physiological substrate.
Material is milled to a target particle size, blended with any flow aid, and packed under controlled humidity in foil or fibre drums with desiccant. Hygroscopicity, not oxidation, is the main stability concern.
Suppliers commonly decline to state whether the underlying L-carnitine came from a synthetic or a fermentation route, and finished labels almost never carry it.
Getting Acetyl-L-Carnitine (Nerve) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
2 more forms
The essence, in one line each.
- The authors of this narrative review state that the long-term neurotrophic and analgesic activity of acetyl-L-carnitine has been confirmed in clinical studies in people with a diagnosed nerve condition.Narrative review, in patients with peripheral neuropathies. Fornasari et al., 2026 (Pain and Therapy). PMID 41824218 ↗
8 more findings
- In a systematic review of studies in people with various diagnosed nervous system conditions, L-carnitine showed favorable effects for cognitive disorders but its efficacy appeared limited for a diagnosed mood condition.Systematic review, in patients suffering from nervous system diseases. Wang et al., 2024 (Nutrients). PMID 38674921 ↗
- In young people with a diagnosed nerve condition, a supplement combination with acetyl-L-carnitine taken alongside a rehabilitation program led to greater improvements in pain and disability scores after 30 days than rehabilitation alone.Randomised trial, in young patients with sciatica due to herniated discs. Scaturro et al., 2023 (Medicina). PMID 38138300 ↗
- The review sets out why carnitine status matters in preterm infants, whose endogenous synthesis capacity is immature, and calls the supplementation evidence in that group unsettled.Narrative review. Sisi et al., 2025 (Frontiers in Nutrition). PMID 40948868 ↗
- Acetyl-L-carnitine is named among agents discussed for oxidative and mitochondrial mechanisms in nerve tissue. The review argues mechanism and does not report a new clinical measurement.Narrative review. Sztanek et al., 2026 (Antioxidants). PMID 41897513 ↗
- Acetyl-L-carnitine appears in a broad catalogue of ergogenic and medical supplements. It is mentioned inside the wider review rather than assessed on its own.Narrative review. Rowland et al., 2026 (Journal of the International Society of Sports Nutrition). PMID 41685663 ↗
- Acetyl-L-carnitine was one of 12 antioxidants evaluated in a systematic review and network meta-analysis of 48 trials in 3,650 children and adolescents with a diagnosed attention disorder, but it was not ranked among the most effective for any of the outcomes measured.Systematic review, in children and adolescents with attention deficit hyperactivity disorder (ADHD). Zhou et al., 2024 (PLoS One). PMID 38547138 ↗
- In a randomised trial in adults with a diagnosed neurodegenerative condition, a supplement containing L-carnitine tartrate and other ingredients taken for 84 days did not improve motor function but was associated with significantly improved cognitive function test scores compared to a placebo.Randomised trial, in Parkinson's disease patients. Yulug et al., 2025 (Brain Communications). PMID 39816194 ↗
- In a systematic review of biomarker studies in people with a diagnosed psychiatric condition, carnitine levels helped identify the condition in people of Miao ethnicity and differed between people of Miao and Han ethnicity.Systematic review, in people with schizophrenia (SCZ). Yao et al., 2025 (Frontiers in Psychiatry). PMID 40225847 ↗
Chosen from the 10 we read for Acetyl-L-Carnitine (Nerve).
The studies, linked.
7 sources behind our Acetyl-L-Carnitine (Nerve) verdict, every one linked to PubMed, the journal or ClinicalTrials.gov.
- Meta-analysisAcetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPubMed ↗PLoS ONE, 2015, cited 47 times, open access
6 more linked trials
- ReviewA randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.PubMed ↗Clinical and experimental rheumatology, 2015, cited 28 times
- Source ↗
- StudyCarnitine Acetyltransferase Mitigates Metabolic Inertia and Muscle Fatigue During ExercisePubMed ↗Cell metabolism, 2015, cited 96 times, open access
- StudyL-Carnitine and Pyruvate Are Prosurvival Factors During the Storage of Stallion Spermatozoa at Room Temperature1PubMed ↗2015, cited 83 times, open access
- StudyAn acetyl-L-carnitine switch on mitochondrial dysfunction and rescue in the metabolomics study on aluminum oxide nanoparticlesPubMed ↗Particle and Fibre Toxicology, 2015, cited 53 times, open access
- StudyHistopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.PubMed ↗Neuroscience letters, 2015, cited 19 times
From clinical trials and PubMed, ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.